下肢动脉旁路术实施加速康复路径可缩短住院时间
本研究在单一机构试点实施下肢动脉旁路术加速康复路径(ERP),20个月内112例患者中60例接受ERP、52例为传统路径。ERP组总住院时间7.8天 vs 13.6天(P=.014),术后住院时间6.0天 vs 11.0天(P=.0058),非计划再手术10.0% vs 28.9%(P=.015)。作者认为ERP在择期和非择期场景均可行,但急诊/紧急指征患者依从性更具挑战。
要点
- ERP组总住院时间7.8天 vs 传统路径13.6天(P=.014),术后住院时间6.0天 vs 11.0天(P=.0058)
- ERP组非计划再手术10.0% vs 传统路径28.9%(P=.015)
- ERP组非计划再入院13.3% vs 传统路径26.9%(P=.095),趋势未达统计学显著
核心结论
- 作者认为下肢动脉旁路术ERP在择期和非择期场景均可行,但急诊或紧急指征患者对个体元素的依从性更具挑战。
- ERP组患者过程指标依从性改善、住院时间缩短且非计划再手术减少。
- 作者指出结果凸显ERP对下肢动脉旁路术及复杂血管外科人群的获益,并提示该人群值得考虑的潜在障碍。
研究设计与样本
- 多利益相关方会议审查现有循证实践并最终确定下肢动脉旁路术ERP,路径元素包括标准化患者教育、最小围术期禁食联合术前碳水化合物负荷、阿片节省镇痛及术后早期饮食和活动。
- ERP于2022年2月作为试点在单一机构启动,20个月时从病历中提取患者数据及过程与结局指标,由四名独立评审员验证后进行单变量分析。
- 研究期间共112例患者接受下肢动脉旁路术,接受>70%路径元素者归入ERP组(n=60),缺失>30%元素者按传统路径分析(n=52)。
主要发现
- ERP组与传统路径组在患者人口学特征、体重指数或血红蛋白A1c方面无显著差异。
- ERP组更可能为择期手术(76.7% vs 48.1%;P=.0004)及慢性肢体威胁性缺血(76.7% vs 48.1%;P=.001),较少为紧急或急诊。
- 膝下旁路靶点频率或手术时长无显著差异。
- ERP组10项围术期过程指标依从性范围为28%至98%,术前教育81.6%、氯己定擦洗80.0%、术后活动90.0%、早期固体饮食98.3%、术后阿片节省策略98.3%依从性最高,术前对乙酰氨基酚28.3%、碳水化合物负荷33.8%、术后蛋白质补充28.3%依从性最具挑战。
- 与传统路径组相比,ERP组总住院时间显著缩短(7.8天 vs 13.6天;P=.014)、术后住院时间显著缩短(6.0天 vs 11.0天;P=.0058)、非计划再手术显著减少(10.0% vs 28.9%;P=.015);非计划再入院有减少趋势(13.3% vs 26.9%;P=.095)。
临床怎么用
- 作者认为下肢动脉旁路术ERP在择期和非择期场景均可行。
- 作者指出急诊或紧急指征患者对ERP个体元素的依从性更具挑战。
- 作者指出结果凸显ERP对下肢动脉旁路术及复杂血管外科人群的获益,并提示该人群值得考虑的潜在障碍。
局限性
- ERP于2022年2月作为试点在单一机构启动。
- 本研究为单变量分析。
- 作者指出急诊或紧急指征患者对ERP个体元素的依从性更具挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Frailty, nutrition, and comorbid conditions are all challenges that contribute to significant morbidity in patients undergoing lower extremity arterial bypass (LEAB). Evidence supports that enhanced recovery pathways (erps) can improve perioperative outcomes. However, few studies have demonstrated successful implementation of an ERP for LEAB. The goal of this study was to demonstrate the successful implementation of an ERP in a complex patient population undergoing LEAB, including elective, urgent, or emergent procedures with the goal of decreasing length of stay (LOS) and morbidity for patients undergoing these procedures at our institution. METHODS: Multistakeholder meetings with representatives from all vascular surgery practice sites in the Northwestern Medicine system were conducted to review current evidence-based practices and finalize an ERP for patients undergoing LEAB. Pathway elements included standardized patient education, minimal perioperative fasting with preoperative carbohydrate loading, opioid-sparing analgesia, and early postoperative diet and mobilization. The ERP was initiated in February 2022 as a pilot at a single institution. At 20 months, patient data and process and outcome measures were abstracted from the medical record and validated by four independent reviewers for univariate analysis. RESULTS: Over the 20-month study period, 112 patients underwent LEAB. Process measures were tracked to determine compliance with the ERP. Patients had to receive >70% of the pathway elements to be considered part of the ERP (n = 60). If patients missed >30% of the elements, they were analyzed as traditional pathway (n = 52). There were no significant differences in patient demographics, body mass index, or hemoglobin a1c. ERP patients were more likely to be elective (76.7% vs 48.1%; P = .0004) and for chronic limb-threatening ischemia (76.7% vs 48.1%; P = .001) and less likely to be urgent or emergent. No significant difference was observed in frequency of infrageniculate bypass target or operative duration. Compliance with 10 perioperative process measures ranged from 28% to 98% in the ERP group. Compliance was most successful with preoperative education (81.6%), chlorhexidine wash (80.0%), postoperative mobilization (90.0%), early solid diet (98.3%), and postoperative opioid sparing strategies (98.3%). Challenges included preoperative acetaminophen (28.3%), carbohydrate load (33.8%), and postoperative protein supplementation (28.3%). Notably, ERP patients demonstrated significantly reduced total LOS (7.8 days vs 13.6 days; P = .014), postoperative LOS (6.0 days vs 11.0 days; P = .0058), and unplanned reoperations (10.0% vs 28.9%; P = .015) when compared with traditional pathway patients. ERP patients trended toward fewer unplanned readmissions (13.3% vs 26.9%; P = .095). CONCLUSIONS: Our findings suggest that an ERP for LEAB is feasible in both elective and nonelective settings, although compliance with the ERP individual elements was more challenging for patients undergoing procedures for emergent or urgent indications. Patients undergoing ERP had improved compliance with process measures, reduced LOS, and fewer unplanned reoperations. Our results highlight the benefits of ERP for LEAB and the complex vascular surgery population and some of the potential barriers worth considering in this patient population.
引用
- Chao CL, Lopes L, Reddy NK, et al. Implementation of enhanced recovery pathway for lower extremity arterial bypass decreases length of stay. J Vasc Surg. 2025. PMID: 40404026. doi:10.1016/j.jvs.2025.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。